Moderna Up Over 15%, Best Performer in the S&P 500 So Far Today -- Data Talk
Dow Jones2026/08/21 14:45Moderna, Inc. (MRNA) is currently at $154.17, up $20.85 or 15.64%
--On pace for largest percent increase since Aug. 19, 2026, when it rose 176.97%
--Currently up three of the past five days
--Up 143.48% this week; best weekly performance on record (Based on available data back to Dec. 7, 2018)
--Up 181.23% month-to-date
--Up 422.79% year-to-date
--Down 68.18% from its all-time closing high of $484.47 on Aug. 9, 2021
--Up 468.47% from 52 weeks ago (Aug. 22, 2025), when it closed at $27.12
--Down 11.59% from its 52-week closing high of $174.38 on Aug. 19, 2026
--Up 589.49% from its 52-week closing low of $22.36 on Nov. 20, 2025
--Traded as high as $159.47
--Up 19.61% at today's intraday high
--Best performer in the S&P 500 today
--Third most active stock in the S&P 500 today
All data as of 10:42:51 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2026 10:45 ET (14:45 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro drifts toward the bottom of its range as US rate bets climb
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.